30 related articles for article (PubMed ID: 21446326)
1. The Influence of Sexual Behavior and Demographic Characteristics in the Expression of HPV-Related Biomarkers in a Colposcopy Population of Reproductive Age Greek Women.
Valasoulis G; Pouliakis A; Michail G; Daponte AI; Galazios G; Panayiotides IG; Daponte A
Biology (Basel); 2021 Jul; 10(8):. PubMed ID: 34439947
[TBL] [Abstract][Full Text] [Related]
2. Urine HPV in the Context of Genital and Cervical Cancer Screening-An Update of Current Literature.
Daponte A; Michail G; Daponte AI; Daponte N; Valasoulis G
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915878
[TBL] [Abstract][Full Text] [Related]
3. Identification of HPV16-p16
Buenahora MR; Lafaurie GI; Perdomo SJ
Epigenetics; 2021 Sep; 16(9):1016-1030. PubMed ID: 33164635
[TBL] [Abstract][Full Text] [Related]
4. p16 immunostaining as a predictor of anal and cervical dysplasia in women attending a sexually transmitted infection clinic.
Pandhi D; Bisherwal K; Singal A; Guleria K; Mishra K
Indian J Sex Transm Dis AIDS; 2016; 37(2):151-156. PubMed ID: 27890949
[TBL] [Abstract][Full Text] [Related]
5. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
6. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
[TBL] [Abstract][Full Text] [Related]
7. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
8. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of p16 immunoreactivity in cervical biopsies: correlation to lesion grade and HPV detection, with a review of the literature.
Kostopoulou E; Samara M; Kollia P; Zacharouli K; Mademtzis I; Daponte A; Messinis IE; Koukoulis G
Eur J Gynaecol Oncol; 2011; 32(1):54-61. PubMed ID: 21446326
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
